Angioplasty. Angioplasty status
Conditions
Interventions
Intervention 1: Intervention group: Routine treatment (angiotensin inhibitors, statin, anti-placket, beta-blockers) plus one capsule Q10 400 mg (manufactured by Dana Pharmaceutical Co.) single dose im
Sponsors
Hamedan University of Medical Sciences
Eligibility
Sex/Gender
All
Age
18 Years to 75 Years
Inclusion criteria
Inclusion criteria: Age 18 to 75 years; Symptoms of persistent myocardial ischemia for at least 30 minutes; Less than 12 hours after the onset of heart attack symptoms; Increased ST segment on electrocardiogram; Treated with primary angioplasty;
Exclusion criteria
Exclusion criteria: Consumption of any antioxidants in the past month; Indication of cardiac bypass surgery; History of myocardial infarction or angioplasty; Indication of thrombolytic therapy; Cardiogenic shock; History of heart failure; Advanced liver failure or autoimmune or inflammatory diseases
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Nephropathy. Timepoint: Before the intervention and 24, 48, 72 hours after the intervention. Method of measurement: By measuring serum levels of BUN, creatinine and Estimated glomerular filtration rate (eGFR). | — |
Secondary
| Measure | Time frame |
|---|---|
| Serum level of CRP. Timepoint: Before the intervention and 24, 48, 72 hours. Method of measurement: After the intervention by laboratory test. | — |
Countries
Iran (Islamic Republic of)
Contacts
Public ContactAyesheh Rahmani
Hamedan University of Medical Sciences
Outcome results
None listed